Nivolumab vs Samarium Sm 153 Lexidronam Pentasodium

## Nivolumab vs Samarium Sm 153 Lexidronam Pentasodium: Overview

This comparison examines the pharmacological differences between **Nivolumab** and **Samarium Sm 153 Lexidronam Pentasodium**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Nivolumab — 27 days; Samarium Sm 153 Lexidronam Pentasodium — N/A.

## Chemical Properties

**Type**: Nivolumab — Antibody; Samarium Sm 153 Lexidronam Pentasodium — Small molecule.